American Heart Journal

Article	Citations
Information for Readers	122
Response to letters-to-the-editor for publication: “Defect-free care trends in the Paul Coverdell National Acute Stroke Program (PCNASP), 2008-2018. American Heart Journal. 2021;232:177-184. doi:10.10	95
Information for Readers	84
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	77
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	69
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging	68
Editorial Board	65
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial	65
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	60
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	58
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	58
Table of Contents	46
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	46
Table of Contents	42
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	40
The trial to assess chelation therapy 2 (TACT2): Rationale and design	36
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	36
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	35
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	33
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	32
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	32
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	31
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States	30
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	30
Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison	29

Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	28
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	27
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	27
Ambulatory inotropic therapy: To what end?	27
Physician responses to apple watch-detected irregular rhythm alerts	27
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality	27
The “Great Wave”: Childhood Obesity and Overweight	26
Editorial Board	25
Table of Contents	24
Information for Readers	23
Clinical Data and Diagnostic findings in Patients with Ischemic Heart Disease undergoing Coronary Angiography: a Cross-sectional study from a Tertiary Hospital in Sudan, Africa	23
Editorial Board	23
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	23
Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial	22
Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators	22
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial	22
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications	22
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinica	22
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial	21
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	21
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	21
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	21
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	21
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy	21
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry	21
Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study	20
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	20
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey	20
Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-Human Primates	20
Prospective randomized comparison between upgraded ‘2C3L’ vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design	20
Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification	20
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	20
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	19
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and prese	19
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	19
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	19
Distal versus conventional radial access for coronary angiography and intervention: Design and rationale of DISCO RADIAL study	18
Perioperative bleeding and outcomes after noncardiac surgery	18
Electronic health record risk score provides earlier prognostication of clinical outcomes in patients admitted to the cardiac intensive care unit	18
Diversity of Electrocardiographic Patterns in Left Main Culprit Acute ST-Elevation Myocardial Infarction	18
Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study	18
Development of a unified national database of primary percutaneous coronary intervention centers with co-located emergency departments, 2020	17
Renin–angiotensin–aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system	17
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial	17
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study	17
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial	17
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis	17
ISCHEMIA-EXTEND studies: Rationale and design	17
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic	17
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease	17

Hypocholesterolemic Effect of Avocado (Persea americana Mill) Juice in Hypercolestrolemic Rats Model	16
Editorial Board	16
Efficacy of Liraglutide Versus Gliclazide in Treatment of Patients with Type II Diabetes Mellitus: Systematic Review and Meta-Analysis	16
Information for Readers	16
Editorial Board	16
High Glucose Suppresses Cardiomyocyte Progenitor Cell Regenerative Capacity and the Role of miR-195/EZH2 Crosstalk in Gestational Diabetes Mellitus	16
Results from a Randomized, Open-Label, Crossover Study Evaluating Pharmacokinetic Interaction Between the Aldosterone Synthase Inhibitor Baxdrostat and Metformin in Healthy Human Subjects	16
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design	15
Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study	15
Towards a person-centered after-visit summary to facilitate improved heart failure care (HF-AVS): A scoping review and call to action	15
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria	15
Type 1 diabetes and oxidative stress markers	15
Patterns of diuretic titration during inpatient management of acute decompensated heart failure	15
Clinical Outcomes in Non-Obese Caucasian and Hispanic Populations with DM, a Nation-Wide Study	15
Tricuspid valve disease prevalence and the impact of tricuspid valve surgery on cardiovascular events and hospital resource use in medicare beneficiaries	15
Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis	15
The Relationship Between Glycemia and Heart Failure in Patients with Coronary Heart Disease and Diabetes Mellitus 2	14
Editorial Board	14
Estimate Patient's 10-Years Cardiovascular Risk using Arteriosclerotic Cardiovascular Disease Tool a Cross-Sectional Study in Al-Harja, Asser, Saudi Arabia, 2021	14
Information for Readers	14
Influence of Prediabetes on Coronary Atherosclerotic Plaque Burden Assessed by Coronary Computed Tomography Angiography (CCTA).	14
Familial Hypercholesterolemia and Type 2 Diabetes: Diagnostic and Therapeutic Challenges	14
Table of Contents	14
Information for Readers	14
Benefits of Fiber-Rich Snacks on Waist Circumference and Atergenic Index of Plasma in Obese	14
Association of change in QRS duration with chronic heart failure outcomes	13
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial	13
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project	13
The Role of Dialysis in Outcomes of LVAD Implantation in Chronic Kidney Disease Patients: Insights from US National Readmission Database	13
Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention	13
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial	13
Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium	13
Framework of the strengths and challenges of clinically integrated trials: An expert panel report	13
Patient characteristics, treatment patterns, and prognosis in drug-use-associated infective endocarditis in Denmark from 1999 to 2018	13
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure	13
Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease	13
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB	13
Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials	12
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial	12
Sex-differences in 5 year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft surgery in patients with Diabetes and Multivessel Disease	12
Editorial Board	12
Prognostic Value of Triglyceride-Glucose Index for the Prediction of Cardiovascular Events: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	12
Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is ‘paroxysmal’ atrial fibrillation?	12
Table of Contents	12
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI	12
Dyslipidaemia Patterns and Risk Factors Among Patients with Diabetes, Hypertension, and Both Diabetes and Hypertension at a Tertiary Hospital in Malawi	12
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial	12
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial	12
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities	12
Editorial Board	12
Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers a	12
Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report	12
Computerized technologies informing cardiac catheterization and guiding coronary intervention	12
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	11
Coarctation of aorta is associated with left ventricular stiffness, left atrial dysfunction and pulmonary hypertension	11
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy	11
Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis aged 70 years or younger: A NOTION-2 substudy	11
Anatomic and physiologic classification of adults with congenital heart disease to predict adverse outcomes: Use of administrative codes compared to clinical staging	11
Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients	11
Dysglycemia and incident heart failure among blacks: The jackson heart study	11
Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of	11
Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries	11
Relationship Between Vaccines Against Coronavirus Disease 2019 (Covid-19) and Myocarditis	11
Sex differences in emergency medical services management of patients with myocardial infarction: analysis of routinely collected data for over 110,000 patients	11
Table of Contents	11
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project	11
Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults	11
Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes	11
Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure	11
Lactate Dehydrogenase can be Considered a Predictive Marker of Severity and Mortality of Covid-19 in Diabetic and Non-Diabetic Patients. A Case Series	10
OCEAN trial update	10
Investigating the Smoker's Paradox: Aortic Stenosis Patient Outcomes in Smokers	10
Table of Contents	10
The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart F	10
Depressive hypertension: A proposed human endotype of brain/gut microbiome dysbiosis	10
The Effect of Avocado Drink (Persea Americana Mill) on the Incidence of Ballooning Hepatocyte in the Liver Organs of Rats (Rattus Novergicus) Induced by Hypercholesterolemia	10
Single Nucleotide Variants of the VDR Gene and Cardiometabolic Risk in Obesity	10
Risk Scale for Patients with Newly Diagnosed Diabetic Foot Ulcer - Which Patients May Experience Healing Failure or Need Revascularization	10
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet	10
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-co	10

A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain	10
Patients Admitted with Metabolic Syndrome and Atrial Fibrillation Have Greater Risk of Adverse Cardiovascular Events and Clinical Outcomes	10
Information for Readers	10
Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients – A Community Pharmacy-Based Survey	10
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy	10
Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes	10
Editorial Board	10
Editorial Board	9
Information for Readers	9
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)	9
EVALUATION OF NEUTROPHIL-LYMPHOCYTE RATIO IN DIABETES AND CORONARY ARTERY DISEASE: A CASE CONTROL STUDY FROM INDIA	9
Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction	9
Table of Contents	9
Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial	9
Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices	9
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for h	9
“Enhancing Cardiac Rehabilitation Adherence Through Home-Based Rehabilitation and Behavioral Nudges: The ERA Nudge Study Design and Rationale”	9
Table of Contents	9
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	9
Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)	9
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design	9
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta	9
Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system	9
Financial burden, distress, and toxicity in cardiovascular disease	9
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	9
Editorial Board	9
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	9
Editorial Board	9
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	9
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design	9
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration	9
Meta‐analysis assessing the sensitivity and specificity of 18F‐FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)	9
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial	9
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia	9
Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study)	8
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study	8
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease	8
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	8
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	8
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	8
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	8
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	8
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	8
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	8
Text messages for primary prevention of cardiovascular disease: The TextMe2 randomized clinical trial	8
Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study	8
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	8
The pathophysiology of patent foramen ovale and its related complications	8
Table of Contents	8
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	8
Ambulatory management of cardiac amyloidosis	8
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	8
Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial	8
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	8
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	8
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	8
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	8
Prevalence and clinical correlates and characteristics of “Super Fontan”	8
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	8
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	8
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	8
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	8
Editorial Board	8
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	7
Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension	7
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	7
Effectiveness of the risk stratification proposed by the 2022 European Heart Rhythm Association Expert Consensus statement on arrhythmic mitral valve prolapse	7
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry	7
Nigella sativa for the management of hyperglycaemia and dyslipidemia	7
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	7
Information for Readers	7
Newer Treatments and Glycemic Control in US Adults With Diabetes Across Risk Groups, Sex, and Ethnicity: The NIH Precision Medicine Initiative (All Of Us Study)	7
Burden of cardiometabolic risk factors and vascular health	7
The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a nonhigh-sensitivity troponin T assay after noncardiac surgery	7
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	7
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	7
MAFLD and Cardiovascular Disease Risk Assessment in the Primary Care Setting	7
The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease	7
Table of Contents	7
Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella	7
Zofenopril Treatment Efficacy on Survival, Endostatin and Insulin-Like Growth Factor-1 in Patients with Diabetes Mellitus Type 2 After Acute Myocardial Infarction	6
Design and rationale of the mobile health intervention for rural atrial fibrillation	6
NOX Subunit Gene Polymorphisms and the Risk of Chronic Artery Disease in Type 2 Diabetes Patients	6
Microalbuminuria in Patients with Type 2 Diabetes Mellitus Treated with a Phytoformula as Adjuvant.	6
To Adjust or Not to Adjust: The Role of Different Covariates in Cardiovascular Observational Studies	6
Telomere, Telomerase and The Aging Heart	6
Editorial Board	6
Diabetes Mellitus and Peripartum Cardiomyopathy: A Nationwide Study	6
The remote exercise SWEDEHEART study–Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)	6
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)	6
Antiplatelet regimens following carotid artery revascularization	6
Evaluation of the beneficial effect of metformin on clinical indicators of heart failure patients with coronary artery disease and impaired glucose tolerance within a 12-month follow-up	6
Comparison of Therapies with GLP1 Analogues in Type 2 Diabetic Patients Without Control	6
Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry	6
High Serum Atherogenicity and the Risk of Developing Type 2 Diabetes Mellitus	6